Definitions
Sorry, no definitions found. You may find more data at ceftobiprole.
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word Ceftobiprole.
Examples
-
Ceftobiprole, which analysts believe could generate $1 billion or more in annual sales, is intended to treat complicated skin infections from drug-resistant superbugs and potentially pneumonia and other infections.
-
Ceftobiprole is a broad-spectrum cephalosporin with activity against MRSA, or methicillin-resistant staphylococcus aureus, a deadly superbug, and is Bailea's lead investigational drug.
Planned 'superbug' antibiotic hits U.S. snag Cassandra Petrakis 2008
-
Ceftobiprole is intended to treat complicated skin infections, such as abscesses, ulcers and diabetics 'foot infections.
-
They include Televancin from Theravance/Astellas and Ceftobiprole from Johnson & Johnson/Basilea, and the stocks then plummet.
Patient Investor: Interview With Tony Yao Leslie P. Norton 2008
-
Ceftobiprole has a broad coverage of both Gram-positive bacteria, including MRSA, and many clinically important Gram-negative bacteria such as Pseudomonas spp.
-
Ceftobiprole has a broad coverage of both Gram-positive bacteria, including MRSA, and many clinically important Gram-negative bacteria such as Pseudomonas spp.
-
Basilea Is in Talks, May Sell Rights to Ceftobiprole This Year Basilea Pharmaceutica AG has started talks with several potential partners and may sell rights to the ceftobiprole experimental antibiotic this year.
unknown title 2011
-
Ceftobiprole may have a peak sales potential of 1.1 billion francs, according to Zilian.
-
Ceftobiprole - a novel broad-spectrum anti-MRSA methicillin-resistant Staphylococcus aureus cephalosporin antibiotic targeting Gram-positive and Gram-negative pathogens, including Pseudomonas aeruginosa, for the potential first-line treatment of severe infections treated in the hospital Basilea regained full rights to ceftobiprole in February 2011.
-
Ceftobiprole is an anti-MRSA broad-spectrum cephalosporin antibiotic exhibiting activity against a wide spectrum of Gram-positive bacteria, including the 'superbug' methicillin-resistant Staphylococcus aureus (MRSA) and penicillin-resistant Streptococcus pneumonia as well as many clinically important Gram-negative bacteria, including Pseudomonas.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.